The independent source for health policy research, polling, and news.
60,941 - 60,960 of 112,415 Results
Ahead of Wednesday's mark-up of the FY 2011 state and foreign ops appropriations bill, Foreign Policy's "The Cable" blog examines recent comments made by House Foreign Operations Subcommittee Chairwoman Nita Lowey (D-N.Y.) in which she "promised
Today's early morning highlights from the major news organizations, including the results of a new tracking poll that indicate that the health reform law has gained popularity among Americans.
Three months after health reform was enacted, state leaders are beginning to make decisions about putting the new law into practice.
Roll Call reports that the death of Sen. Robert Byrd, D-W.Va., has jeopardized further the passage of bills in Congress, including a bill that would extend unemployment benefits.
Congress' rejection - at least for now - of a package extending $16 billion in Medicaid funding and $35.5 billion in other jobless benefits has left at least 30 states struggling to balance next fiscal year's budgets with tax increases, spending cuts and layoffs.
The automaker Ford may pay part of the $859 million it owes a union health care fund with company stock, a move analysts say would show weakness.
States address a range of health care policy issues.
As the Senate Health, Education, Labor and Pensions Committee holds a hearing today on a proposed fund to cover additional health care costs for first responders to the Sept. 11, 2001, attacks, Senate Republicans are planning to take issue with the management of the fund, CongressDaily reports.
Kaiser Health News presents a selection of Tuesday's opinions and editorials from around the country.
USAID will contribute $11.5 million for the Market Linkages Initiative (MLI), a two-year program aimed at promoting trade in "staple foods" in East Africa, the Daily Nation reports.
The Hill reports that doctors who belong to the American Society of Interventonal Pain Physicians want lawmakers to give money to help states begin collecting data on patients who "doctor shop" looking for pain pill or other prescriptions.
"The world's anti-poverty gains achieved over the past years are being eroded by the presence of multiple crises, including an unprecedented economic and financial crisis, increased food [in]security, oil prices volatility and climate change," according to a report released Monday by U.N. Secretary-General Ban Ki-moon during the opening of an annual high-level segment of the U.N. Economic and Social Council (ECOSOC), Bermana reports.
Greenwire/New York Times reports on the growing number of cases of dengue worldwide, including the CDC's report last month that the virus has now been locally acquired in the continental U.S. for the first time in 65 years. "While a few cases were reported earlier, they were primarily in Americans who had caught the virus abroad or at the Texas-Mexico border," the news service writes.
The plan seeks to advance a more coordinated approach even as state budgets face difficulties.
Chinese and U.S. health officials opened an epidemiology center in Shanghai Tuesday to train experts to deal with and prevent chronic and epidemic diseases, the Associated Press reports.
The FDA's new rare disease review group will hold its first public hearing on Tuesday and Wednesday to discuss how to expand efforts to develop treatments for rare diseases that affect fewer than 200,000 people, Reuters. "The new rare disease review group is part of a broadened effort to encourage companies to spend more money on the more than 6,000 rare diseases identified," Reuters writes, adding that the FDA "already offer[s] companies grants and guaranties seven years of market exclusivity for drugs that treat rare diseases."
News outlets offer consumer guides to health insurance for part-time workers, changes to Medigap coverage and how to make sure patients are not overcharged for medical services.
Both the new health care law and the Medicare program are pushing doctors, nurses and hospitals to prepare for a spike in older patients.
Questions about the drug's safety have been raised before and the controversy goes to the heart of FDA oversight.
© 2026 KFF